IS
Iqbal Singh
About Iqbal Singh
Data last updated:
Iqbal Singh is a Director at Shaolin Lifescience Private Limited (since 2023). The companies operate in Trading. Shaolin Lifescience Private Limited reported revenue of ₹19.9 Lakh (FY 2025). Earlier, Iqbal Singh was a Director at Moonlight Pharmaceuticals Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shaolin Lifescience Private Limited U51909RJ2017PTC059750 | Director | 08 Feb 2023 | 2017 | ₹19.9 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Moonlight Pharmaceuticals Private Limited U24232RJ2009PTC029468 | Director | 28 Jul 2009 | 2009 | ₹32.1 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Iqbal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kiran Jeet Kaur | 07993697 | Shaolin Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Iqbal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iqbal Singh
Iqbal Singh currently holds 1 directorship: Shaolin Lifescience Private Limited (Director, since 08 Feb 2023, revenue ₹19.9 Lakh (FY 2025)).
Iqbal Singh was first appointed on 28 Jul 2009 as Director at Moonlight Pharmaceuticals Private Limited. The most recent appointment on record is 08 Feb 2023 at Shaolin Lifescience Private Limited.
Iqbal Singh held 1 earlier board appointment: Moonlight Pharmaceuticals Private Limited (Director, from 28 Jul 2009).
The current boards of Iqbal Singh's companies include Kiran Jeet Kaur (Shaolin Lifescience Private Limited).